 |
answer text |
<p>Under the 2014 Pharmaceutical Price Regulation Scheme (PPRS), scheme members made
payments to the Department. The 2014 PPRS has now delivered over £2.7 billion of PPRS
payments. The following table shows the annual aggregate PPRS payments from 2014 until
the end of the PPRS in December 2018. The 2019 Voluntary Scheme for Branded Medicines
Pricing and Access is the current voluntary scheme.</p><table><tbody><tr><td><p>Period</p></td><td><p>Aggregate
PPRS payments</p></td></tr><tr><td><p>2014</p></td><td><p>£311 million</p></td></tr><tr><td><p>2015</p></td><td><p>£847
million</p></td></tr><tr><td><p>2016</p></td><td><p>£628 million</p></td></tr><tr><td><p>2017</p></td><td><p>£387
million</p></td></tr><tr><td><p>2018</p></td><td><p>£615 million</p></td></tr></tbody></table><p>
</p><p>Further aggregate net sales and payment information can be found at the following
link:</p><p><a href="https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information"
target="_blank">https://www.gov.uk/government/collections/pprs-quarterly-net-sales-and-payment-information</a></p><p>Each
year, the Department estimates the England share of expected income from the PPRS
which is then included within NHS England baseline financial allocations. Decisions
on how to allocate funding across the health system is for NHS England to determine,
in line with patient need.</p>
|
|
